These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 33242441)

  • 1. Targeted therapy or transplantation for paediatric ABL-class Ph-like acute lymphocytic leukaemia?
    Tasian SK; Peters C
    Lancet Haematol; 2020 Dec; 7(12):e858-e859. PubMed ID: 33242441
    [No Abstract]   [Full Text] [Related]  

  • 2. Philadelphia-positive Acute Lymphoblastic Leukemia: Do We Still Need Allogeneic Transplantation? Argument "Pro".
    Bachanova V
    Clin Lymphoma Myeloma Leuk; 2017 Jul; 17S():S10-S15. PubMed ID: 28760293
    [No Abstract]   [Full Text] [Related]  

  • 3. Successful second allogeneic stem cell transplantation in second remission induced by dasatinib in a child with Philadelphia chromosome positive acute lymphoblastic leukemia.
    Millot F; Cividin M; Brizard F; Chomel JC; Méchinaud F; Guilhot F
    Pediatr Blood Cancer; 2009 Jul; 52(7):891-2. PubMed ID: 19202569
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Philadelphia chromosome-positive acute lymphoblastic leukemia with an e14a3 BCR-ABL1 fusion: The role of molecular monitoring.
    Crampe M; Langabeer SE; O'Brien D; Ryan E; Bacon CL
    Hematol Oncol Stem Cell Ther; 2020 Sep; 13(3):166-167. PubMed ID: 31158331
    [No Abstract]   [Full Text] [Related]  

  • 5. [Molecular response and prognostic factors of patients with Philadelphia chromosome/BCR-ABL-positive acute lymphoblastic leukemia treated by imatinib with chemotherapy].
    Wang J; Huang X; Jiang B; Qin Y; Bao L; Jiang H; Chen H; Jia J; Yang S; Jiang Q
    Zhonghua Xue Ye Xue Za Zhi; 2014 Feb; 35(2):120-5. PubMed ID: 24606652
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Haploidentical hematopoietic stem cell transplantation for pediatric Philadelphia chromosome-positive acute lymphoblastic leukemia in the imatinib era.
    Chen H; Liu KY; Xu LP; Chen YH; Zhang XH; Wang Y; Qin YZ; Liu YR; Lai YY; Huang XJ
    Leuk Res; 2017 Aug; 59():136-141. PubMed ID: 28654842
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Cytogenetic and prognostic analysis in adult patients with Philadelphia chromosome-positive and bcr-abl positive acute lymphoblastic leukaemia].
    Li YN; Zou DH; Gu M; Zhao YZ; Qi JY; Mi YC; Wang JX; Qiu LG
    Zhonghua Xue Ye Xue Za Zhi; 2009 May; 30(5):298-302. PubMed ID: 19799123
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular measurement of minimal residual disease in Philadelphia-positive acute lymphoblastic leukaemia.
    Radich JP
    Best Pract Res Clin Haematol; 2002 Mar; 15(1):91-103. PubMed ID: 11987918
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Detection of the BCR-ABL gene by reverse transcription/polymerase chain reaction and fluorescence in situ hybridization in a patient with Philadelphia chromosome negative acute lymphoblastic leukaemia.
    van Rhee F; Kasprzyk A; Jamil A; Dickinson H; Lin F; Cross NC; Galvin MC; Goldman JM; Secker-Walker LM
    Br J Haematol; 1995 May; 90(1):225-8. PubMed ID: 7786793
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Outcome of treatment in adults with Philadelphia chromosome-positive and/or BCR-ABL--positive acute lymphoblastic leukemia-retrospective analysis of Polish Adult Leukemia Group (PALG).
    Wrzesień-Kuś A; Robak T; Pluta A; Zwolińska M; Wawrzyniak E; Wierzbowska A; Skotnicki A; Jakubas B; Hołowiecki J; Nowak K; Kuliczkowski K; Mazur G; Haus O; Dmoszyńska A; Adamczyk-Cioch M; Jedrzejczak WW; Paluszewska M; Konopka L; Pałynyczko G
    Ann Hematol; 2006 Jun; 85(6):366-73. PubMed ID: 16523310
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Emerging BCR/ABL1 Mutations Under Treatment with Tyrosine Kinase Inhibitors in Paediatric Acute Lymphoblastic Leukaemia.
    Molinos-Quintana A; Aquino V; Montero I; Pérez-de Soto C; García-Lozano R; Pérez-Simón JA; Pérez-Hurtado JM
    Acta Haematol; 2015; 134(2):71-5. PubMed ID: 25895602
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Haploidentical hematopoietic stem cell transplantation without in vitro T cell depletion for the treatment of philadelphia chromosome-positive acute lymphoblastic leukemia.
    Chen H; Liu KY; Xu LP; Chen YH; Han W; Zhang XH; Wang Y; Qin YZ; Liu YR; Huang XJ
    Biol Blood Marrow Transplant; 2015 Jun; 21(6):1110-6. PubMed ID: 25698612
    [TBL] [Abstract][Full Text] [Related]  

  • 13. How I treat Philadelphia chromosome-positive acute lymphoblastic leukemia.
    Ravandi F
    Blood; 2019 Jan; 133(2):130-136. PubMed ID: 30442680
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predictors of relapse and overall survival in Philadelphia chromosome-positive acute lymphoblastic leukemia after transplantation.
    Stirewalt DL; Guthrie KA; Beppu L; Bryant EM; Doney K; Gooley T; Appelbaum FR; Radich JP
    Biol Blood Marrow Transplant; 2003 Mar; 9(3):206-12. PubMed ID: 12652472
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The molecular pathogenesis of the Philadelphia-positive leukemias: implications for diagnosis and therapy.
    Van Etten RA
    Cancer Treat Res; 1993; 64():295-325. PubMed ID: 8095796
    [No Abstract]   [Full Text] [Related]  

  • 16. Philadelphia chromosome-positive acute lymphoblastic leukemia- current concepts and future perspectives.
    Faderl S; Garcia-Manero G; Thomas DA; Kantarjian HM
    Rev Clin Exp Hematol; 2002 Jun; 6(2):142-60; discussion 200-2. PubMed ID: 12196213
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The first case of acute lymphoblastic leukemia with the e19a2 BCR-ABL1 transcript: imatinib therapy followed by unrelated donor transplantation induces a durable molecular response.
    Jeon EK; Lim J; Kim M; Yahng SA; Lee SE; Cho BS; Kim YJ; Kim HJ; Min CK; Cho SG; Kim DW; Lee JW; Min WS; Park CW; Lee S
    Leukemia; 2011 Feb; 25(2):366-7. PubMed ID: 21072049
    [No Abstract]   [Full Text] [Related]  

  • 18. Leukemia cell lines: in vitro models for the study of Philadelphia chromosome-positive leukemia.
    Drexler HG; MacLeod RA; Uphoff CC
    Leuk Res; 1999 Mar; 23(3):207-15. PubMed ID: 10071072
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tyrosine kinase inhibitor prophylaxis after transplant for Philadelphia chromosome-positive acute lymphoblastic leukemia.
    Akahoshi Y; Nishiwaki S; Mizuta S; Ohashi K; Uchida N; Tanaka M; Fukuda T; Ozawa Y; Takahashi S; Onizuka M; Shiratori S; Nakamae H; Kanda Y; Ichinohe T; Atsuta Y; Kako S;
    Cancer Sci; 2019 Oct; 110(10):3255-3266. PubMed ID: 31402561
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The functional interplay between the t(9;22)-associated fusion proteins BCR/ABL and ABL/BCR in Philadelphia chromosome-positive acute lymphatic leukemia.
    Rafiei A; Mian AA; Döring C; Metodieva A; Oancea C; Thalheimer FB; Hansmann ML; Ottmann OG; Ruthardt M
    PLoS Genet; 2015 Apr; 11(4):e1005144. PubMed ID: 25919613
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.